EnWave (ENW) Q1 2025 earnings summary

Executive summary

• Q1 2025 saw increased third-party royalty revenues, reaching CAD 559,000, up 16% year-over-year, driven by more partners and exclusivity payments.

• Total Q1 2025 revenue was CAD 1.2 million, down 7% year-over-year due to lower equipment sales, partially offset by higher royalties and tolling.

• Gross margin improved to 29% from 18% in the prior year, reflecting increased royalties and tolling fees.

• Adjusted EBITDA loss narrowed to CAD 624,000, a year-over-year improvement.

• Five additional agreements were signed post-Q1, including license amendments and equipment sales in Peru, Spain, and Brazil.

Financial highlights

• Direct costs decreased 19% year-over-year to CAD 837,000, supporting margin improvement.

• SG&A expenses, including R&D, remained flat at CAD 1.3 million, with higher tradeshow costs offset by lower legal expenses.

• Loss per share from continuing operations was $0.00, compared to $(0.01) in Q1 2024.

• Net loss from continuing operations was CAD 938,000, an 18% improvement year-over-year; net loss from discontinued operations was CAD 8,000.

• Sales and marketing efforts intensified, with new hires and participation in global trade shows.

Outlook and guidance

• Management expects material revenue impact from large-scale REV machine sales in upcoming quarters.

• Anticipates break-even or better performance within fiscal 2025, contingent on closing large-scale sales.

• Ongoing collaborations in the pharmaceutical sector may yield additional sales this year.

• Focus remains on leveraging patented REVTM technology to drive partner growth and recurring royalty streams.